Skip to content
Search

Latest Stories

PSNI appoints Michaela McAleer as its new chief executive

The Pharmaceutical Society NI (PSNI) has announced that Michaela McAleer will be replacing Trevor Patterson as Chief Executive of PSNI.

After 15 years at the helm, Patterson announced his intention to retire. Jonathan Patton, Vice President of the Society said, “Joining the Society from the construction sector Trevor brought fresh thinking and vigour to the Society and quickly established his credibility with pharmacists, Council, stakeholders and fellow regulatory bodies.”


“Trevor has presided over tremendous change and development through his tenure with equal measures of professionalism and passion on creating safer protections for the public and ensuring pharmacists achieved world class standards in their profession. We are saddened to see him depart but on behalf of Council I wish him a long and healthy retirement and wish him well in the next chapter of life. We are indebted to him for his dedication to the Pharmaceutical Society NI.”

“Losing the constant and continuity of our 15 year serving Chief Executive ushers in a time of change and evolution for us as the Pharmacy Regulator. We are in the midst of a fast moving and changing environment as we implement continuous improvement.

McAleer will take up her appointment on 5th December 2022, on her appointment Patton commented: “The experience Michaela brings with her from her extensive roles in Regulation provides the Society and the public with the assurance that the evolution will continue at pace and that we will strengthen the already strong relationships and professionalism we bring to the world of Pharmacy. Staff and Council are looking forward to working with her and progressing the exciting and important work of the Pharmaceutical Society.”

Michaela McAleer brings to the role 20 years public sector experience in the oversight of public bodies through independent investigation of complaints and the regulation of statutory codes of conduct. (Formerly, the Acting Deputy Commissioner for Local Government Standards at the Northern Ireland Public Services Ombudsman she has investigated alleged breaches of the Code of Conduct for Northern Ireland Councillors and led the first ‘Own Investigation’ undertaken by a UK Ombudsman under new statutory powers introduced in April 2018.)

More recently she has extended her experience in regulation to include that of the UK press and serves as a non executive director for the Independent Press Standards Organisation.

Michaela McAleer said: “I am delighted to be taking on the role of Chief Executive at this challenging time for pharmacists and the health system across the region. I am looking forward to working alongside the new President of the Council and its members continuing and building upon the work of the current Chief Executive, Trevor Patterson, regulating to ensure the delivery of safe and trusted care to the public by the pharmacy profession”.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less